A new cancer drug developed in Kazakhstan is in the final stages of clinical trials. The drug works by increasing oxidative stress, which leads to the destruction of cancer cells. Researchers are currently working to determine the optimal formulation and dosage to achieve the desired effect. However, definitive conclusions about its effectiveness will only be drawn after analysing patient outcomes. The new drug and other advances in oncology were discussed at an international scientific conference in the capital. Participants paid particular attention to cancer diagnosis and treatment methods, including theranostics and immunotherapy.
«Right now, our goal is to achieve a strong effect. Some drugs inhibit cell growth and proliferation. These are known as cytostatic agents. Others are cytotoxic agents, which kill cancer cells. We are developing our drug specifically to kill cancer cells, and that is what we are working towards,» said Dos Sarbassov, professor at Nazarbayev University and general director of National Laboratory Astana.
Related Articles
